BRAFGene Mutations Are Rare Events in Gastroenteropancreatic Neuroendocrine Tumors
نویسندگان
چکیده
منابع مشابه
Gastroenteropancreatic neuroendocrine tumors (GEP-NETS)
1 Medical Student, Universidad de Antioquia, Medellín, Colombia. Gastrohepatology Group. Universidad de Antioquia. Medellín, Colombia. email: crivargas@ gmail.com 2 Gastrointestinal Surgeon and Endoscopist, Hospital Pablo Tobón Uribe, Medellín, Colombia. Professor of Surgery, Universidad Pontificia Bolivariana. Medellín, Colombia. Gastrohepatology Group. Universidad de Antioquia, Medellín, Colo...
متن کاملNutrition and gastroenteropancreatic neuroendocrine tumors.
Gastroenteropancreatic (GEP) neuroendocrine tumors (NETs) are relatively rare neoplasms that characteristically synthesize and secrete an excess of a variety of regulatory peptides, hormones, and neuroamines, which regulate gut and pancreatic function. This excess can lead to distinct clinical syndromes. Therapeutic strategies include surgery, radiofrequency ablation, chemotherapy, chemoemboliz...
متن کاملNovel agents in gastroenteropancreatic neuroendocrine tumors.
Neuroendocrine tumors (NET) are a diverse group of tumors that derive from epithelial cells with neuroendocrine differentiation. Gastroenteropancreatic neuroendocrine tumors are a subset of NET that arises in the gastrointestinal tract. Clinical symptoms and presentations vary depending on the location and hormones produced by the tumor. Treatment of advanced and metastatic gastroenteropancreat...
متن کاملEndoscopic Ultrasound in Gastroenteropancreatic Neuroendocrine Tumors
Endoscopic ultrasound (EUS) is an advanced endoscopic technique currently used in the staging and diagnosis of many gastrointestinal neoplasms. The proximity of the echoendoscope to the gastrointestinal tract lends itself to a detailed view of the luminal pathology and the pancreas. This unique ability enables endoscopists to use EUS in patients with gastroenteropancreatic neuroendocrine tumors...
متن کاملGastroenteropancreatic neuroendocrine tumors: hormonal treatment updates.
Gastroenteropancreatic neuroendocrine tumors are a heterogeneous group of carcinomas that remain difficult to treat with conventional cytotoxic regimens. The 2014 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium brought us new insights into the management of gastroenteropancreatic neuroendocrine tumors. The focus of this review will serve to highlight specific Abs...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: American Journal of Clinical Pathology
سال: 2005
ISSN: 0002-9173,1943-7722
DOI: 10.1309/yqbr9c05ru4dd3rn